The information provided in this table is also available in an ASCII text file (TXT, 5 KB) (semicolons are used as the delimiters).
To see how this variable is used with SEER data and the other lymphoma variable definition, see the Lymphoma Subtype Recode home page.
Site Group | Grade | Primary Site | Histology ICD-O-3 | Recode |
---|---|---|---|---|
Lymphoid Neoplasm | ||||
1. Hodgkin Lymphoma | ||||
1(a). Classical Hodgkin lymphoma | ||||
1(a)1. Lymphocyte-rich/mixed cellularity/lymphocyte depleted | ||||
1(a)1.1. Lymphocyte-rich | 0-9 | C000-C809 | 9651 | 01 |
1(a)1.2. Mixed cellularity | 0-9 | C000-C809 | 9652 | 02 |
1(a)1.3. Lymphocyte-depleted | 0-9 | C000-C809 | 9653-9655 | 03 |
1(a)2. Nodular sclerosis | 0-9 | C000-C809 | 9663-9667 | 04 |
1(a)3. Classical Hodgkin lymphoma, NOS | 0-9 | C000-C809 | 9650, 9661-9662 | 05 |
1(b). Nodular lymphocyte predominant Hodgkin lymphoma | 0-9 | C000-C809 | 9659 | 06 |
2. Non-Hodgkin lymphoma | ||||
2(a). Non-Hodgkin lymphoma, B-cell | ||||
2(a)1. Precursor Non-Hodgkin lymphoma, B-cell | 0-9 | C000-C809 | 9728, 9836 | 07 |
6 | C000-C809 | 9727, 9835 | 07 | |
2(a)2. Mature Non-Hodgkin lymphoma, B-cell | ||||
2(a)2.1. Chronic/Small/Prolymphocytic/Mantle B-cell NHL | ||||
2(a)2.1.1. Chronic/Small lymphocytic leuk/lymph | 0-9 | C000-C809 | 9670, 9823 | 08 |
2(a)2.1.2. Prolymphocytic leukemia, B-cell | 0-9 | C000-C809 | 9833 | 09 |
6 | C000-C809 | 9832 | 09 | |
2(a)2.1.3. Mantle-cell lymphoma | 0-9 | C000-C809 | 9673 | 10 |
2(a)2.2. Lymphoplasmacytic lymphoma/Waldenstrom | ||||
2(a)2.2.1. Lymphoplasmacytic lymphoma | 0-9 | C000-C809 | 9671 | 11 |
2(a)2.2.2. Waldenstrom macroglubulinemia | 0-9 | C000-C809 | 9761 | 12 |
2(a)2.3. Diffuse large B-cell lymphoma (DLBCL) | ||||
2(a)2.3.1. DLBCL, NOS | 0-9 | C000-C498, C500-C809 | 9680 | 13 |
6 | C000-C809 | 9684 | 13 | |
2(a)2.3.2. Intravascular large B-cell lymphoma | 0-9 | C499 | 9680 | 14 |
2(a)2.3.3. Primary effusion lymphoma | 0-9 | C000-C809 | 9678 | 15 |
2(a)2.3.4. Mediastinal large B-cell lymphoma | 0-9 | C000-C809 | 9679 | 16 |
2(a)2.4. Burkitt lymphoma/leukemia | 0-9 | C000-C809 | 9687, 9826 | 17 |
2(a)2.5. Marginal-zone lymphoma (MZL) | ||||
2(a)2.5.1. Splenic MZL | 0-9 | C000-C809 | 9689 | 18 |
2(a)2.5.2. Extranodal MZL, MALT type | 0-9 | C000-C769, C780-C809 | 9699 | 19 |
0-9 | C000-C809 | 9760, 9764 | 19 | |
2(a)2.5.3. Nodal MZL | 0-9 | C770-C779 | 9699 | 20 |
2(a)2.6. Follicular lymphoma | 0-9 | C000-C809 | 9690-9691, 9695, 9698 | 21 |
2(a)2.7. Hairy-cell leukemia | 0-9 | C000-C809 | 9940 | 22 |
2(a)2.8. Plasma cell neoplasms | ||||
2(a)2.8.1. Plasmacytoma | 0-9 | C000-C809 | 9731, 9734 | 23 |
2(a)2.8.2. Multiple myeloma/plasma-cell leuk. | 0-9 | C000-C809 | 9732-9733 | 24 |
2(a)2.9. Heavy chain disease | 0-9 | C000-C809 | 9762 | 25 |
2(a)3. Non-Hodgkin lymphoma, B-cell, NOS | 6 | C000-C809 | 9591, 9675 | 26 |
2(b). Non-Hodgkin lymphoma, T-cell | ||||
2(b)1. Precursor Non-Hodgkin lymphoma, T-cell | 0-9 | C000-C809 | 9729, 9837 | 27 |
5, 7, 8 | C000-C809 | 9727, 9835 | 27 | |
2(b)2. Mature Non-Hodgkin lymphoma, T-cell | ||||
2(b)2.1. Mycosis fungoides/Sezary syndrome | ||||
2(b)2.1.1. Mycosis fungoides | 0-9 | C000-C809 | 9700 | 28 |
2(b)2.1.2. Sezary syndrome | 0-9 | C000-C809 | 9701 | 29 |
2(b)2.2. Peripheral T-cell lymphoma | ||||
2(b)2.2.1. Peripheral T-cell lymphoma, NOS | 0-9 | C000-C809 | 9702 | 30 |
5, 7, 8 | C000-C809 | 9675 | 30 | |
2(b)2.2.2. Angioimmunoblastic T-cell lymphoma | 0-9 | C000-C809 | 9705 | 31 |
2(b)2.2.3. Subcutaneous panniculitis-like T-cell lymphoma | 0-9 | C000-C809 | 9708 | 32 |
2(b)2.2.4. Anaplastic large cell lymphoma, T- or Null-cell | 0-9 | C000-C809 | 9714 | 33 |
2(b)2.2.5. Hepatosplenic T-cell lymphoma | 0-9 | C000-C809 | 9716 | 34 |
2(b)2.2.6. Enteropathy-type T-cell lymphoma | 0-9 | C000-C809 | 9717 | 35 |
2(b)2.2.7. Cutaneous T-cell lymphoma, NOS | 0-9 | C000-C809 | 9709 | 36 |
2(b)2.2.8. Primary cutaneous anaplastic large cell lymphoma | 0-9 | C000-C809 | 9718 | 37 |
2(b)2.3. Adult T-cell leukemia/lymphoma | 0-9 | C000-C809 | 9827 | 38 |
2(b)2.4. NK/T-cell lymph., nasal-type/aggressive NK leuk. | 0-9 | C000-C809 | 9719, 9948 | 39 |
2(b)2.5. T-cell large granular lymphocytic leukemia | 0-9 | C000-C809 | 9831 | 40 |
2(b)2.6. Prolymphocytic leukemia, T-cell | 0-9 | C000-C809 | 9834 | 41 |
5, 7, 8 | C000-C809 | 9832 | 41 | |
2(b)3. Non-Hodgkin lymphoma, NOS, T-cell | 5, 7, 8 | C000-C809 | 9591, 9684 | 42 |
2(c). Non-Hodgkin lymphoma, unknown lineage | ||||
2(c)1. Precursor lymphoblastic leuk/lymph, unknown lineage | 1-4, 9 | C000-C809 | 9727, 9835 | 43 |
2(c)2. Prolymphocytic leukemia, unknown lineage | 1-4, 9 | C000-C809 | 9832 | 44 |
2(c)3. Non-Hodgkin lymphoma, NOS, unknown lineage | 1-4, 9 | C000-C809 | 9591, 9675, 9684 | 45 |
3. Composite Hodgkin lymphoma and NHL | 0-9 | C000-C809 | 9596 | 46 |
4. Lymphoid neoplasm, NOS | 0-9 | C000-C809 | 9590, 9594, 9820, 9970 | 47 |
Unclassified | 99 |
* Adapted from Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.